Percentage expression of CD25 and Ki67 cellular markers from lymph node aspirates of dogs with B-cell lymphoma appear to be promising prognostic indicators in clinical investigations, however this needs to be translated into clinical practice. This evidence concerns the gene MKI67 and B-cell non-Hodgkin lymphoma.